EverSource Wealth Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.6K Buy
1,066
+474
+80% +$4.57K ﹤0.01% 2622
2026
Q1
$4.39K Buy
592
+266
+82% +$2.8K ﹤0.01% 3329
2025
Q4
$3.83K Sell
326
-536
-62% -$5.78K ﹤0.01% 3226
2025
Q3
$6.66K Sell
862
-65
-7% -$455 ﹤0.01% 3023
2025
Q2
$6.78K Buy
927
+598
+182% +$4.83K ﹤0.01% 3027
2025
Q1
$3.12K Sell
329
-416
-56% -$5.19K ﹤0.01% 2716
2024
Q4
$12.3K Sell
745
-360
-33% -$5.59K ﹤0.01% 1889
2024
Q3
$16.3K Buy
1,105
+227
+26% +$3.55K ﹤0.01% 1598
2024
Q2
$15.6K Buy
878
+11
+1% +$156 ﹤0.01% 1625
2024
Q1
$12.1K Buy
867
+15
+2% +$232 ﹤0.01% 1596
2023
Q4
$13.8K Buy
852
+345
+68% +$5.64K ﹤0.01% 1415
2023
Q3
$6.24K Sell
507
-238
-32% -$3.54K ﹤0.01% 1612
2023
Q2
$12K Buy
745
+160
+27% +$2.64K ﹤0.01% 1365
2023
Q1
$10.2K Sell
585
-51
-8% -$727 ﹤0.01% 1346
2022
Q4
$5.88K Buy
636
+103
+19% +$960 ﹤0.01% 1539
2022
Q3
$5K Hold
533
﹤0.01% 1383
2022
Q2
$4K Buy
533
+327
+159% +$3.12K ﹤0.01% 1331
2022
Q1
$3K Hold
206
﹤0.01% 1432
2021
Q4
$7K Buy
+206
New +$8.07K ﹤0.01% 1123

Other funds holding NEO

EverSource Wealth Advisors's NEO Position: Q2 2026 in Review

EverSource Wealth Advisors increased its NeoGenomics (NEO) stake by 80% in Q2 2026, buying an estimated $4.57K and bringing the position to 1,066 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2622.

EverSource Wealth Advisors first reported a position in NEO in Q4 2021 and has held it in 19 quarters since. The position peaked at $16.3K in Q3 2024. 69 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • EverSource Wealth Advisors held 1,066 shares of NeoGenomics worth $15.6K as of Q2 2026.
  • EverSource Wealth Advisors bought 474 NeoGenomics shares in Q2 2026, an estimated $4.57K.
  • NeoGenomics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2622 holding.
  • EverSource Wealth Advisors first reported a position in NeoGenomics in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's NeoGenomics position peaked at $16.3K in Q3 2024.
  • 69 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.